Skip to content

Impact of the Age Difference Between the Donor and Recipient on the Morbidity and Mortality After Lung Transplantation. Study on a National Multicenter Cohort (COLT)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02855372
Enrollment
800
Registered
2016-08-04
Start date
2016-10-31
Completion date
2018-04-30
Last updated
2016-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Transplantation

Brief summary

It is commonly accepted that the characteristics of the organ donor impact on the future post transplant. In lung transplantation (LP), the defining characteristics of the ideal donor includes an age less than 55 years. However, before the pulmonary graft shortage with a corresponding mortality still too high waiting list, the lung graft acceptance criteria were reassessed permitting criteria extension ( marginal graft). And were grafted, depending on the urgency and accessibility problems in the registry of potential candidate, organs from donors aged 55 and older with quite comparable to those obtained from younger donors . Nevertheless, it is common practice that the grafts from older donors are more readily allocated to older candidates and the most severe, as many confounding factors to assess the real impact of donor age on post-transplant evolution on small cohorts. The main goal of this study is to compare the survival of lung transplant patients depending on the age difference between donor and recipient. The study will be conducted from a broad national cohort of lung transplant patients registered in COLT ( Lung Transplantation COhort). Established in September 2009, promoted by the University Hospital of Nantes, COLT involves 11 lung transplant centers authorized on French territory. It provides a standardized common longitudinal monitoring of the recipient from his transplant. Currently more than 1,000 patients included in this study are transplanted.

Interventions

PROCEDURELung transplantation

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female adult patients, included in COLT cohort, thus having given a signed written consent * Who received a lung transplant

Exclusion criteria

* Lung transplanted patients in a context of national priority * Lung transplanted patients who died within 3 months after the surgery * Patients for whom it is a second lung transplantation

Design outcomes

Primary

MeasureTime frameDescription
Age difference in years between donor and recipient1 dayThe age difference will then be able to define two groups of patients: * 1 group with an age difference \< 10 years * 1 group with an age difference \> 10 years

Countries

France

Contacts

Primary ContactUrielle DESALBRES
urielle.desalbres@ap-hm.fr04 91 38 20 61

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026